{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:06:02Z","timestamp":1793066762625,"version":"4.5.0"},"reference-count":161,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["AGL2017-84097-C2-2-R"],"award-info":[{"award-number":["AGL2017-84097-C2-2-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["MDM-2014-0370"],"award-info":[{"award-number":["MDM-2014-0370"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>For decades, natural products in general and snake venoms (SV) in particular have been a rich source of bioactive compounds for drug discovery, and they remain a promising substrate for therapeutic development. Currently, a handful of SV-based drugs for diagnosis and treatment of various cardiovascular disorders and blood abnormalities are on the market. Likewise, far more SV compounds and their mimetics are under investigation today for diverse therapeutic applications, including antibiotic-resistant bacteria and cancer. In this review, we analyze the state of the art regarding SV-derived compounds with therapeutic potential, focusing on the development of antimicrobial and anticancer drugs. Specifically, information about SV peptides experimentally validated or predicted to act as antimicrobial and anticancer peptides (AMPs and ACPs, respectively) has been collected and analyzed. Their principal activities both in vitro and in vivo, structures, mechanisms of action, and attempts at sequence optimization are discussed in order to highlight their potential as drug leads.<\/jats:p>","DOI":"10.3390\/toxins12040255","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T09:19:50Z","timestamp":1586942390000},"page":"255","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs"],"prefix":"10.3390","volume":"12","author":[{"given":"Clara","family":"P\u00e9rez-Peinado","sequence":"first","affiliation":[{"name":"Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sira","family":"Defaus","sequence":"additional","affiliation":[{"name":"Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andreu","sequence":"additional","affiliation":[{"name":"Department of Experimental and Health Science, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/0929867324666170605091546","article-title":"Snake Venom: From Deadly Toxins to Life-saving Therapeutics","volume":"24","author":"Waheed","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","article-title":"A bradykinin-potentiating factor (BPF) present in the venom of bothrops jararaca","volume":"24","author":"Ferreira","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents","volume":"196","author":"Ondetti","year":"1977","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fpubh.2014.00145","article-title":"The antimicrobial resistance crisis: Causes, consequences, and management","volume":"2","author":"Michael","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_5","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T Peer-Rev. J. Formul. Manag."},{"key":"ref_6","unstructured":"O\u2019Neill, J. (2014). Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist."},{"key":"ref_7","unstructured":"O\u2019Neill, J. (2016). Tackling drug-resistant infection globally: Final report and recommendations. Rev. Antimicrob. Resist."},{"key":"ref_8","unstructured":"(2019, August 06). WHO. 2018. Cancer Fact Sheets. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_9","unstructured":"Ferlay, J.E.M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2018). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/today."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: Globocan sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_12","unstructured":"Shaz, B.H., Hillyer, C.D., and Reyes Gil, M. (2019). Chapter 164\u2014Diagnostic Use of Venoms. Transfusion Medicine and Hemostasis, Elsevier. [3rd ed.]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s00018-006-6315-0","article-title":"Snake venom components and their applications in biomedicine","volume":"63","author":"Koh","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_14","unstructured":"Wexler, P. (2014). Animal Venoms in Medicine. Encyclopedia of Toxicology, Academic Press. [3rd ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: Translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2174\/138161207782023739","article-title":"Approaching the golden age of natural product pharmaceuticals from venom libraries: An overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications","volume":"13","author":"Fox","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/bies.201000117","article-title":"Snake venom: From fieldwork to the clinic: Recent insights into snake biology, together with new technology allowing high-throughput screening of venom, bring new hope for drug discovery","volume":"33","author":"Vonk","year":"2011","journal-title":"Bioessays"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/vec.12337","article-title":"Prospective evaluation of the incidence of wound infection in rattlesnake envenomation in dogs","volume":"25","author":"Carr","year":"2015","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ecam\/neh063","article-title":"Snake Venom: Any Clue for Antibiotics and CAM?","volume":"2","author":"Santos","year":"2005","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/164.1.195","article-title":"Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria","volume":"164","author":"Talan","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.biochi.2008.04.007","article-title":"Purification, characterization and bactericidal activities of basic phospholipase A2 from the venom of Agkistrodon halys (Chinese pallas)","volume":"90","author":"Gopalakrishnakone","year":"2008","journal-title":"Biochimie"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0041-0101(91)90210-I","article-title":"Antibacterial effects of different snake venoms: Purification and characterization of antibacterial proteins from Pseudechis australis (Australian king brown or mulga snake) venom","volume":"29","author":"Stiles","year":"1991","journal-title":"Toxicon"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Perumal Samy, R., Pachiappan, A., Gopalakrishnakone, P., Thwin, M.M., Hian, Y.E., Chow, V.T., Bow, H., and Weng, J.T. (2006). In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei. BMC Infect. Dis., 6.","DOI":"10.1186\/1471-2334-6-100"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0024-3205(87)90126-3","article-title":"Cytotoxic activity of various snake venoms on melanoma, B16F10 and chondrosarcoma","volume":"40","author":"Ovadia","year":"1987","journal-title":"Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09629350220131953","article-title":"Antitumor effect of Bothrops jararaca venom","volume":"11","author":"Vilela","year":"2002","journal-title":"Mediat. Inflamm."},{"key":"ref_26","first-page":"93","article-title":"Anticancer potential of animal venoms and toxins","volume":"48","author":"Gomes","year":"2010","journal-title":"Indian J. Exp. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxicon.2018.05.004","article-title":"Whole snake venoms: Cytotoxic, anti-metastatic and antiangiogenic properties","volume":"150","author":"Kerkkamp","year":"2018","journal-title":"Toxicon"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"196754","DOI":"10.1155\/2014\/196754","article-title":"Snake venom L-amino acid oxidases: Trends in pharmacology and biochemistry","volume":"2014","author":"Izidoro","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ddr.21456","article-title":"Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance","volume":"80","author":"Almeida","year":"2019","journal-title":"Drug Dev. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jprot.2018.08.004","article-title":"Transcriptome-facilitated proteomic characterization of rear-fanged snake venoms reveal abundant metalloproteinases with enhanced activity","volume":"187","author":"Modahl","year":"2018","journal-title":"J. Proteom."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcp.21373","article-title":"Viper metalloproteinase (Agkistrodon halys pallas) with antimicrobial activity against multi-drug resistant human pathogens","volume":"216","author":"Samy","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.toxicon.2012.09.004","article-title":"Snake venom metalloproteinases","volume":"62","author":"Markland","year":"2013","journal-title":"Toxicon"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sala, A., Cabassi, C.S., Santospirito, D., Polverini, E., Flisi, S., Cavirani, S., and Taddei, S. (2018). Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190778"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.fob.2015.10.004","article-title":"Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent","volume":"5","author":"Samy","year":"2015","journal-title":"FEBS Open Bio"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.toxicon.2010.01.011","article-title":"Crotoxin: Novel activities for a classic beta-neurotoxin","volume":"55","author":"Sampaio","year":"2010","journal-title":"Toxicon"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Samy, R.P., Kandasamy, M., Gopalakrishnakone, P., Stiles, B.G., Rowan, E.G., Becker, D., Shanmugam, M.K., Sethi, G., and Chow, V.T. (2014). Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0080199"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e22018","DOI":"10.1002\/jbt.22018","article-title":"Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom","volume":"32","author":"Allane","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxicon.2017.05.019","article-title":"Venom of the Peruvian snake Bothriopsis oligolepis: Detection of antibacterial activity and involvement of proteolytic enzymes and C-type lectins in growth inhibition of Staphylococcus aureus","volume":"134","author":"Sulca","year":"2017","journal-title":"Toxicon"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2011.10.012","article-title":"BJcuL, a lectin purified from Bothrops jararacussu venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly","volume":"59","author":"Nolte","year":"2012","journal-title":"Toxicon"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cbpb.2011.02.001","article-title":"Purification of a lectin with antibacterial activity from Bothrops leucurus snake venom","volume":"159","author":"Vaz","year":"2011","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"203639","DOI":"10.1155\/2014\/203639","article-title":"Antitumoral activity of snake venom proteins: New trends in cancer therapy","volume":"2014","author":"Calderon","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.toxicon.2004.12.011","article-title":"Purification and characterization of a novel peptide with antifungal activity from Bothrops jararaca venom","volume":"45","author":"Gomes","year":"2005","journal-title":"Toxicon"},{"key":"ref_43","first-page":"696","article-title":"Cytotoxic effect of ICD-85 (venom-derived peptides) on HeLa cancer cell line and normal LK cells using MTT Assay","volume":"15","author":"Sarzaeem","year":"2012","journal-title":"Arch. Iran. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1007\/s00018-013-1345-x","article-title":"Snake venoms: Attractive antimicrobial proteinaceous compounds for therapeutic purposes","volume":"70","author":"Cardoso","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100908","DOI":"10.18632\/oncotarget.21740","article-title":"Venom-based peptide therapy: Insights into anti-cancer mechanism","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biopha.2017.04.030","article-title":"Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria","volume":"90","author":"Swain","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","article-title":"Multifunctional cationic host defence peptides and their clinical applications","volume":"68","author":"Yeung","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","article-title":"Designing improved active peptides for therapeutic approaches against infectious diseases","volume":"36","author":"Gomes","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"Hancock","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","article-title":"Molecular mechanisms of membrane targeting antibiotics","volume":"1858","author":"Epand","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1535-7163.MCT-08-0010","article-title":"Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice","volume":"7","author":"Xu","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.3390\/ijms12118027","article-title":"Oncolytic activities of host defense peptides","volume":"12","author":"Shai","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1007\/s00018-017-2604-z","article-title":"Tumor cell membrane-targeting cationic antimicrobial peptides: Novel insights into mechanisms of action and therapeutic prospects","volume":"74","author":"Baxter","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/138920111796117300","article-title":"Anti-angiogenic peptides for cancer therapeutics","volume":"12","author":"Rosca","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1096\/fj.03-1009fje","article-title":"Regulation of neovascularization by human neutrophil peptides (alpha-defensins): A link between inflammation and angiogenesis","volume":"18","author":"Chavakis","year":"2004","journal-title":"FASEB J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1349-7006.1997.tb00364.x","article-title":"Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice","volume":"88","author":"Yoo","year":"1997","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3390\/ph8040711","article-title":"Antimicrobial Peptides from Plants","volume":"8","author":"Tam","year":"2015","journal-title":"Pharmaceuticals"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0924-8579(03)00180-8","article-title":"Antimicrobial peptides in animals and their role in host defences","volume":"22","author":"Brogden","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2174\/1568026618666181112143351","article-title":"Natural-based Antibiofilm and Antimicrobial Peptides from Microorganisms","volume":"18","author":"Yazici","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2672.2012.05338.x","article-title":"Natural antimicrobial peptides from bacteria: Characteristics and potential applications to fight against antibiotic resistance","volume":"113","author":"Hassan","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/13892037113149990067","article-title":"Cathelicidins: Peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities","volume":"14","author":"Wong","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5114\/ceji.2015.51359","article-title":"Cathelicidin impact on inflammatory cells","volume":"40","author":"Agier","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.4049\/jimmunol.174.7.4271","article-title":"Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities","volume":"174","author":"Braff","year":"2005","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1389203053027520","article-title":"The cathelicidins\u2014Structure, function and evolution","volume":"6","author":"Tomasinsig","year":"2005","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9","article-title":"Structural features and biological activities of the cathelicidin-derived antimicrobial peptides","volume":"55","author":"Gennaro","year":"2000","journal-title":"Biopolymers"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/10425170600760125","article-title":"Cloning and characterization of novel cathelicidin cDNA sequence of Bubalus bubalis homologous to Bos taurus cathelicidin-4","volume":"17","author":"Das","year":"2006","journal-title":"DNA Seq."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.45.1.331-334.2001","article-title":"The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection","volume":"45","author":"Brogden","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.45.10.2695-2702.2001","article-title":"RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey","volume":"45","author":"Zhao","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"22742","DOI":"10.1074\/jbc.272.36.22742","article-title":"Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation","volume":"272","author":"Nagaoka","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.272.20.13088","article-title":"Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse","volume":"272","author":"Gallo","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s000180300045","article-title":"Phylogeny, processing and expression of the rat cathelicidin rCRAMP: A model for innate antimicrobial peptides","volume":"60","author":"Termen","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1074\/jbc.M507180200","article-title":"Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity","volume":"281","author":"Xiao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.peptides.2008.06.008","article-title":"Identification and characterization of novel reptile cathelicidins from elapid snakes","volume":"29","author":"Zhao","year":"2008","journal-title":"Peptides"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.peptides.2003.08.024","article-title":"Hagfish intestinal antimicrobial peptides are ancient cathelicidins","volume":"24","author":"Uzzell","year":"2003","journal-title":"Peptides"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1038\/s41598-018-29444-0","article-title":"An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment","volume":"8","author":"Junior","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.peptides.2010.05.005","article-title":"Structure-function relationship of king cobra cathelicidin","volume":"31","author":"Zhang","year":"2010","journal-title":"Peptides"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijbiomac.2016.02.061","article-title":"Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli ATP synthase","volume":"87","author":"Azim","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/AAC.06304-11","article-title":"Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models","volume":"56","author":"Li","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_82","first-page":"87","article-title":"King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates","volume":"39","author":"Zhao","year":"2018","journal-title":"Zool. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3724\/SP.J.1141.2009.02171","article-title":"Effects of the Antimicrobial Peptide OH-CATH on Escherichia coli","volume":"30","author":"Chen","year":"2009","journal-title":"Zool. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00726-014-1801-4","article-title":"Vipericidins: A novel family of cathelicidin-related peptides from the venom gland of South American pit vipers","volume":"46","author":"Falcao","year":"2014","journal-title":"Amino Acids"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12275-018-7444-5","article-title":"The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus","volume":"56","author":"Tajbakhsh","year":"2018","journal-title":"J. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Tajbakhsh, M., Akhavan, M.M., Fallah, F., and Karimi, A. (2018). A Recombinant Snake Cathelicidin Derivative Peptide: Antibiofilm Properties and Expression in Escherichia coli. Biomolecules, 8.","DOI":"10.3390\/biom8040118"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acs.jmedchem.5b01264","article-title":"A Designed Tryptophan- and Lysine\/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis","volume":"59","author":"Jin","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.intimp.2018.10.030","article-title":"Pretreatment with cathelicidin-BF ameliorates Pseudomonas aeruginosa pneumonia in mice by enhancing NETosis and the autophagy of recruited neutrophils and macrophages","volume":"65","author":"Liu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.vetimm.2017.09.005","article-title":"Effects of cathelicidin-derived peptide from reptiles on lipopolysaccharide-induced intestinal inflammation in weaned piglets","volume":"192","author":"Zhang","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.molpharmaceut.5b00069","article-title":"Cathelicidin-BF, a Novel Antimicrobial Peptide from Bungarus fasciatus, Attenuates Disease in a Dextran Sulfate Sodium Model of Colitis","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.intimp.2015.05.034","article-title":"Cathelicidin-BF suppresses intestinal inflammation by inhibiting the nuclear factor-kappaB signaling pathway and enhancing the phagocytosis of immune cells via STAT-1 in weanling piglets","volume":"28","author":"Yi","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.intimp.2015.01.017","article-title":"Antimicrobial peptide Cathelicidin-BF prevents intestinal barrier dysfunction in a mouse model of endotoxemia","volume":"25","author":"Song","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.028","article-title":"BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice","volume":"707","author":"Wang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.peptides.2011.04.002","article-title":"The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity","volume":"32","author":"Zhou","year":"2011","journal-title":"Peptides"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Z., Chen, L., Guang, H., Li, Z., Yang, H., Li, J., You, D., Yu, H., and Lai, R. (2011). Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022120"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.peptides.2011.10.005","article-title":"Structure-activity relationships of a snake cathelicidin-related peptide, BF-15","volume":"32","author":"Chen","year":"2011","journal-title":"Peptides"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Wang, Y., Hong, J., Liu, X., Yang, H., Liu, R., Wu, J., Wang, A., Lin, D., and Lai, R. (2008). Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003217"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbrc.2010.04.073","article-title":"Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella","volume":"396","author":"Amer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2010.04.158","article-title":"Antimicrobial activity of the Naja atra cathelicidin and related small peptides","volume":"396","author":"Amer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmicb.2011.00128","article-title":"Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37","volume":"2","author":"Dean","year":"2011","journal-title":"Front. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Dean, S.N., Bishop, B.M., and van Hoek, M.L. (2011). Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-114"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/antibiotics4030358","article-title":"Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics","volume":"4","author":"Gupta","year":"2015","journal-title":"Antibiotics"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Blower, R.J., Barksdale, S.M., and van Hoek, M.L. (2015). Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003862"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/21505594.2017.1293227","article-title":"Cathelicidin peptide rescues G. mellonella infected with B. anthracis","volume":"9","author":"Blower","year":"2017","journal-title":"Virulence"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1074\/jbc.M115.642645","article-title":"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism","volume":"290","author":"Wei","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1038\/s41598-019-42537-8","article-title":"Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection","volume":"9","author":"Carlile","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1021\/acs.jmedchem.5b01142","article-title":"Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity","volume":"58","author":"Falcao","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ja.2016.135","article-title":"Anti-fungal activity of Ctn[15\u201334], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin","volume":"70","author":"Cavalcante","year":"2016","journal-title":"J. Antibiot."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S0031182017001846","article-title":"Antichagasic effect of crotalicidin, a cathelicidin-like vipericidin, found in Crotalus durissus terrificus rattlesnake\u2019s venom gland","volume":"145","author":"Bandeira","year":"2017","journal-title":"Parasitology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cyto.2018.09.011","article-title":"Antimicrobial and proinflammatory effects of two vipericidins","volume":"111","author":"Freire","year":"2018","journal-title":"Cytokine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxicon.2017.02.031","article-title":"Evaluation of the antichagasic activity of batroxicidin, a cathelicidin-related antimicrobial peptide found in Bothrops atrox venom gland","volume":"130","author":"Mello","year":"2017","journal-title":"Toxicon"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/acs.jmedchem.8b00036","article-title":"Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality","volume":"61","author":"Cai","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00530-17","DOI":"10.1128\/AAC.00530-17","article-title":"Genome wide analysis of the antimicrobial peptides in Python bivittatus and characterization of cathelicidins with potent antimicrobial activity and low cytotoxicity","volume":"61","author":"Kim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2108\/zs180064","article-title":"Characterization of a Cathelicidin from the Colubrinae Snake, Sinonatrix annularis","volume":"36","author":"Wang","year":"2019","journal-title":"Zool. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2--a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: A worldwide hub of protein knowledge","volume":"47","author":"UniProt","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.bbamem.2015.07.006","article-title":"The structure and behavior of the NA-CATH antimicrobial peptide with liposomes","volume":"1848","author":"Du","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bip.22244","article-title":"Characterization and performance of short cationic antimicrobial peptide isomers","volume":"100","author":"Juba","year":"2013","journal-title":"Biopolymers"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bbamem.2016.05.015","article-title":"Membrane phase characteristics control NA-CATH activity","volume":"1858","author":"Samuel","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micres.2014.12.009","article-title":"The antimicrobial peptide cathelicidin-BF could be a potential therapeutic for Salmonella typhimurium infection","volume":"171","author":"Xia","year":"2015","journal-title":"Microbiol. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1074\/jbc.RA117.000125","article-title":"Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom","volume":"293","author":"Dias","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1099\/jmm.0.000652","article-title":"Insights into the candidacidal mechanism of Ctn[15\u201334]\u2014A carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins","volume":"67","author":"Cavalcante","year":"2018","journal-title":"J. Med Microbiol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Mu, L., Tang, J., Duan, Z., Wang, F., Wei, L., Rong, M., and Lai, R. (2013). A small peptide with therapeutic potential for inflammatory acne vulgaris. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072923"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/psc.2488","article-title":"Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro","volume":"19","author":"Hao","year":"2013","journal-title":"J. Pept. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3892\/or.2013.2693","article-title":"The cathelicidin-BF Lys16 mutant Cbf-K16 selectively inhibits non-small cell lung cancer proliferation in vitro","volume":"30","author":"Tian","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Fang, Y., He, X., Zhang, P., Shen, C., Mwangi, J., Xu, C., Mo, G., Lai, R., and Zhang, Z. (2019). In Vitro and In Vivo Antimalarial Activity of LZ1, a Peptide Derived from Snake Cathelicidin. Toxins, 11.","DOI":"10.3390\/toxins11070379"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Li, L., Wang, Q., Li, H., Yuan, M., and Yuan, M. (2014). Preparation, characterization, in vitro release and degradation of cathelicidin-BF-30-PLGA microspheres. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100809"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Bao, Y., Wang, S., Li, H., Wang, Y., Chen, H., and Yuan, M. (2018). Characterization, Stability and Biological Activity In Vitro of Cathelicidin-BF-30 Loaded 4-Arm Star-Shaped PEG-PLGA Microspheres. Molecules, 23.","DOI":"10.3390\/molecules23020497"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00253-013-5246-6","article-title":"Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO technology","volume":"98","author":"Luan","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10295-014-1582-5","article-title":"Expression and one-step purification of the antimicrobial peptide cathelicidin-BF using the intein system in Bacillus subtilis","volume":"42","author":"He","year":"2015","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"103372","DOI":"10.1016\/j.jprot.2019.04.022","article-title":"Decoding the human serum interactome of snake-derived antimicrobial peptide Ctn[15\u201334]: Toward an explanation for unusually long half-life","volume":"204","author":"Defaus","year":"2019","journal-title":"J. Proteom."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e3195","DOI":"10.1002\/psc.3195","article-title":"Structural determinants conferring unusual long life in human serum to rattlesnake-derived antimicrobial peptide Ctn[15\u201334]","volume":"25","author":"Dias","year":"2019","journal-title":"J. Pept. Sci."},{"key":"ref_134","first-page":"414","article-title":"The antiproliferative peptide Ctn[15\u201334] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans","volume":"2","author":"Falcao","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12560-017-9285-5","article-title":"Antiviral Activity of Ctn[15\u201334], A Cathelicidin-Derived Eicosapeptide, Against Infectious Myonecrosis Virus in Litopenaeus vannamei Primary Hemocyte Cultures","volume":"9","author":"Falcao","year":"2017","journal-title":"Food Environ. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: New development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_137","unstructured":"DeLano, W.L. (2002). The PyMOL Molecular Graphics System, DeLano Scientific."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10529-005-0936-5","article-title":"Human antimicrobial peptides: Defensins, cathelicidins and histatins","volume":"27","author":"Contreras","year":"2005","journal-title":"Biotechnol. Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: Antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.toxicon.2013.02.013","article-title":"Phylogenetic analysis of beta-defensin-like genes of Bothrops, Crotalus and Lachesis snakes","volume":"69","author":"Correa","year":"2013","journal-title":"Toxicon"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/ph7060723","article-title":"Antimicrobial peptides in reptiles","volume":"7","year":"2014","journal-title":"Pharmaceuticals"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.toxicon.2018.02.048","article-title":"Beta-defensin genes of the Colubridae snakes Phalotris mertensi, Thamnodynastes hypoconia, and T. strigatus","volume":"146","author":"Correa","year":"2018","journal-title":"Toxicon"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1107\/S0907444913018003","article-title":"Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus","volume":"69","author":"Coronado","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"675985","DOI":"10.1155\/2014\/675985","article-title":"State of the art in the studies on crotamine, a cell penetrating peptide from South American rattlesnake","volume":"2014","author":"Kerkis","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ja.2011.10","article-title":"In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus","volume":"64","author":"Oguiura","year":"2011","journal-title":"J. Antibiot."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biochi.2012.09.019","article-title":"Unraveling the antifungal activity of a South American rattlesnake toxin crotamine","volume":"95","author":"Yamane","year":"2013","journal-title":"Biochimie"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/13543784.2011.602064","article-title":"Crotamine toxicity and efficacy in mouse models of melanoma","volume":"20","author":"Pereira","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/mp2000605","article-title":"The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells","volume":"9","author":"Nascimento","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamem.2016.11.002","article-title":"CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties","volume":"1859","author":"Ponnappan","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1747-0285.2012.01377.x","article-title":"Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells","volume":"79","author":"Andreu","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/bip.22610","article-title":"Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types","volume":"104","author":"Rodrigues","year":"2015","journal-title":"Biopolymers"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"40097","DOI":"10.1074\/jbc.M305322200","article-title":"Identification of a novel family of proteins in snake venoms. Purification and structural characterization of nawaprin from Naja nigricollis snake venom","volume":"278","author":"Torres","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/BJ20060318","article-title":"Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins","volume":"402","author":"Nair","year":"2007","journal-title":"Biochem. J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/pro.468","article-title":"Determination of the X-ray structure of the snake venom protein omwaprin by total chemical synthesis and racemic protein crystallography","volume":"19","author":"Banigan","year":"2010","journal-title":"Protein Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13205-019-1801-x","article-title":"Biological characterization of omw1 and omw2: Antimicrobial peptides derived from omwaprin","volume":"9","author":"Thankappan","year":"2019","journal-title":"3 Biotech"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/472032a","article-title":"Fix the antibiotics pipeline","volume":"472","author":"Cooper","year":"2011","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mib.2015.08.005","article-title":"In the midst of the antimicrobial discovery conundrum: An overview","volume":"27","author":"Tomaras","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.molonc.2014.07.011","article-title":"Acquired and intrinsic resistance in cancer immunotherapy","volume":"8","author":"Kelderman","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"D1094","DOI":"10.1093\/nar\/gkv1051","article-title":"CAMPR3: A database on sequences, structures and signatures of antimicrobial peptides","volume":"44","author":"Waghu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: A database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/4\/255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:30:49Z","timestamp":1760362249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/4\/255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":161,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["toxins12040255"],"URL":"https:\/\/doi.org\/10.3390\/toxins12040255","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]}}}